Eiger BioPharmaceuticals Lands $1,100,000 Series A Financing

  • Feed Type
  • Date
    9/8/2014
  • Company Name
    Eiger BioPharmaceuticals
  • Mailing Address
    1115 Lafayette St. Santa Clara, CA 95050 USA
  • Company Description
    Eiger BioPharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis.
  • Website
    http://www.eigerbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,100,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy